Abstract
This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of autologous blood product injections including PRP, for people with knee osteoarthritis, in terms of pain, function, treatment success, quality of life, disease progression and adverse events.
| Original language | English |
|---|---|
| Article number | CD013341 |
| Number of pages | 15 |
| Journal | Cochrane Database of Systematic Reviews |
| Volume | 2019 |
| Issue number | 5 |
| DOIs | |
| Publication status | Published - 23 May 2019 |
Cite this
}
Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee (Protocol). / Whittle, Samuel L.; Johnston, Renea V.; McDonald, Steve; Paterson, Kade L.; Buchbinder, Rachelle.
In: Cochrane Database of Systematic Reviews, Vol. 2019, No. 5, CD013341, 23.05.2019.Research output: Contribution to journal › Article › Research › peer-review
TY - JOUR
T1 - Autologous blood product injections including platelet-rich plasma for osteoarthritis of the knee (Protocol)
AU - Whittle, Samuel L.
AU - Johnston, Renea V.
AU - McDonald, Steve
AU - Paterson, Kade L.
AU - Buchbinder, Rachelle
PY - 2019/5/23
Y1 - 2019/5/23
N2 - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of autologous blood product injections including PRP, for people with knee osteoarthritis, in terms of pain, function, treatment success, quality of life, disease progression and adverse events.
AB - This is a protocol for a Cochrane Review (Intervention). The objectives are as follows: To assess the benefits and harms of autologous blood product injections including PRP, for people with knee osteoarthritis, in terms of pain, function, treatment success, quality of life, disease progression and adverse events.
UR - http://www.scopus.com/inward/record.url?scp=85066837263&partnerID=8YFLogxK
U2 - 10.1002/14651858.CD013341
DO - 10.1002/14651858.CD013341
M3 - Article
AN - SCOPUS:85066837263
VL - 2019
JO - Cochrane Database of Systematic Reviews
JF - Cochrane Database of Systematic Reviews
SN - 1469-493X
IS - 5
M1 - CD013341
ER -